Skip to main content
    M

    MetaVia Inc. (MTVA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.21
    -0.10 (-7.31%)

    Market Cap: $8.56M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    MetaVia Inc. (MTVA) Earnings: Report Dates and Results

    Updated Nov 13, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    MetaVia (MTVA) is expected to report earnings on Mar 24, 2027. In the quarter ended Sep 30, 2026, MetaVia reported EPS of -$0.69, above the -$0.94 estimate. It beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    65%(20/31)
    Avg Surprise
    +3.05%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.77
    Range-$0.96 - -$0.37
    5 analysts
    Revenue Consensus
    N/A
    RangeN/A
    5 analysts

    Next Report

    MTVA has an expected report date of Mar 24, 2027.

    Earnings History

    Of the 31 quarters below that had an estimate, MTVA beat 20 and missed 11. The widest gap in the table came in the quarter ended Mar 31, 2021, when EPS landed 531.58% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.69-$0.94-$0.94 - -$0.33+26.60%BeatN/A31 up, 0 downNov 13, 2026
    Jun 30, 2026-$0.90-$0.85-$0.87 - -$0.76-5.88%MissN/A30 up, 1 downAug 6, 2026
    Mar 31, 2026-$0.79-$0.75-$0.77 - -$0.74-5.33%MissN/A20 up, 0 downMay 14, 2026
    Sep 30, 2025-$1.54-$2.75-$3.85 - -$1.54+44.00%BeatN/A41 up, 2 downNov 6, 2025
    Jun 30, 2025-$0.26-$0.32N/A+18.75%BeatN/AN/AN/AAug 7, 2025
    Mar 31, 2025-$0.36-$0.30N/A-20.00%MissN/A10 up, 0 downMay 14, 2025
    Dec 31, 2024-$3.52-$8.14-$8.14 - -$8.14+56.76%BeatN/A10 up, 0 downMar 20, 2025
    Sep 30, 2024-$6.05-$8.03N/A+24.66%BeatN/AN/AN/ANov 7, 2024
    Jun 30, 2024-$20.35-$12.36N/A-64.64%MissN/AN/AN/AAug 14, 2024
    Mar 31, 2024-$1.32-$3.63N/A+63.64%BeatN/AN/AN/AMay 9, 2024
    Dec 31, 2023-$25.08-$8.63N/A-190.61%Miss-608.7%N/AN/AMar 28, 2024
    Sep 30, 2023-$7.92-$9.68N/A+18.18%BeatN/AN/AN/ANov 13, 2023
    Jun 30, 2023-$1.76-$1.43N/A-23.08%MissN/AN/AN/AAug 9, 2023
    Mar 31, 2023-$5.28-$55.44N/A+90.48%BeatN/AN/AN/AMay 12, 2023
    Dec 31, 2022$4.93-$1.20N/A+510.83%BeatN/AN/AN/AMar 31, 2023
    Sep 30, 2022-$308.00-$448.80N/A+31.37%BeatN/AN/AN/ANov 14, 2022
    Jun 30, 2022-$0.12-$5.10N/A+97.65%BeatN/AN/AN/AAug 16, 2022
    Mar 31, 2022-$0.17-$0.16N/A-6.25%MissN/AN/AN/AMay 25, 2022
    Sep 30, 2021-$422.40-$475.20N/A+11.11%BeatN/AN/AN/ANov 15, 2021
    Jun 30, 2021-$475.20-$396.00N/A-20.00%MissN/AN/AN/AAug 16, 2021
    Mar 31, 2021-$3,168.00-$501.60N/A-531.58%MissN/AN/AN/AApr 15, 2021
    Sep 30, 2020-$501.60-$448.80N/A-11.76%MissN/AN/AN/ANov 13, 2020
    Jun 30, 2020-$396.00-$712.80N/A+44.44%BeatN/AN/AN/AAug 11, 2020
    Mar 31, 2020-$792.00-$264.00N/A-200.00%MissN/AN/AN/AMay 20, 2020
    Dec 31, 2019-$0.73-$2.25N/A+67.56%BeatN/AN/AN/AMar 30, 2020
    Sep 30, 2019-$6.00-$0.11N/AN/AN/AN/AN/AN/ADec 27, 2019
    Jun 30, 2019-$5.00-$0.12N/AN/AN/AN/AN/AN/AAug 9, 2019
    Mar 31, 2019-$6.75-$0.42N/AN/AN/AN/AN/AN/AMay 6, 2019
    Dec 31, 2018-$6.50-$0.41N/AN/AN/AN/AN/AN/AMar 31, 2019
    Sep 30, 2018-$10.75-$11.75N/A+8.51%BeatN/AN/AN/ANov 8, 2018
    Jun 30, 2018-$11.75-$13.75N/A+14.55%BeatN/AN/AN/AAug 13, 2018
    Mar 31, 2018-$14.50-$16.75N/A+13.43%BeatN/AN/AN/AMay 8, 2018
    Dec 31, 2017-$0.63-$0.69N/A+8.70%BeatN/AN/AN/AMar 31, 2018
    Sep 30, 2017-$0.63-$0.68N/A+7.62%BeatN/AN/AN/ANov 15, 2017
    Jun 30, 2017-$0.75-$0.88N/A+14.77%BeatN/AN/AN/ASep 13, 2017
    Mar 31, 2017-$4,723.76N/AN/AN/AN/AN/AN/AN/AMay 9, 2017
    Dec 31, 2016-$4,672.28N/AN/AN/AN/AN/AN/AN/AMar 31, 2017
    Sep 30, 2016-$3,389.34N/AN/AN/AN/AN/AN/AN/ANov 2, 2016
    Jun 30, 2016-$2,549.34N/AN/AN/AN/AN/AN/AN/AAug 31, 2016
    Last 39 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$2.16, after -$31.24 the year before. It was -$10,610.95 for the year ended Dec 31, 2016, the oldest of the 8 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$2.16N/A
    Dec 31, 2024-$31.24N/A
    Dec 31, 2023-$40.04N/A
    Dec 31, 2022-$6,058.56N/A
    Dec 31, 2019-$18.48N/A
    Dec 31, 2018-$43.50N/A
    Dec 31, 2017-$4,725.77N/A
    Dec 31, 2016-$10,610.95N/A

    Frequently Asked Questions About MTVA

    When is MetaVia's next earnings date?

    MetaVia's next earnings report is expected for Mar 24, 2027.

    Did MTVA beat earnings estimates last quarter?

    Yes. MetaVia reported EPS of -$0.69 for the quarter ended Sep 30, 2026, above the -$0.94 estimate, a 26.60% surprise.

    What EPS do analysts expect from MTVA next quarter?

    The consensus EPS estimate for MetaVia for the quarter ending Dec 31, 2026 is -$0.77 from 5 analysts, with estimates from -$0.96 to -$0.37.

    How often does MTVA beat earnings estimates?

    MetaVia beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate, with an average surprise of +17.44%.